Paediatric HIV

LIVING Study Phase III

NCT02346487 |  Kenya, Uganda

Lopinavir/ritonavir pellets with dual NRTIs  implemenation study  in infants and young children.


Ritonavir superboosting study for TB/HIV Phase IV

NCT02348177  |  South Africa  |  Completed

Pharmacokinetics of lopinavir/ritonavir superboosting in Infants and young children co-infected with HIV and TB.


Last update: January 2019